VAT + Fibromyalgia

What Researchers Studied

Researchers investigated whether 40Hz low-frequency sound stimulation (LFSS), a form of Vibroacoustic Therapy, could significantly reduce fibromyalgia symptoms, improve function, and enhance quality of life in women diagnosed with fibromyalgia.

What They Did

• 19 female participants

• Median age: 51

• Diagnosed fibromyalgia duration: ~5.76 years

• 10 Vibroacoustic Therapy sessions over 5 weeks

• 23-minute sessions

• 40Hz full-body low-frequency sound stimulation

• Measured:

  • Fibromyalgia Impact Questionnaire (FIQ)

  • Jenkins Sleep Scale

  • Pain Disability Index

  • Sitting/standing without pain

  • Cervical ROM

  • Muscle tone

  • Medication use

Key Outcomes

Major Findings:

• 81% improvement in Fibromyalgia Impact Questionnaire scores

• 90% improvement in sleep scores

• 49% reduction in pain disability

• 73.68% reduced medication use

• 26.32% completely discontinued pain medication

Additional Reported Benefits:

• Significant reduction in pain

• Improved mood

• Improved activities of daily living

• Increased sitting tolerance

• Increased standing tolerance

• Improved cervical mobility

• Reduced muscle hypertonicity

• No adverse effects reported

Clinical Implication

This peer-reviewed clinical study found Vibroacoustic Therapy produced statistically and clinically relevant improvements in fibromyalgia symptoms, sleep, pain, mobility, and medication reduction.

Why It Matters

This research suggests Vibroacoustic Therapy may offer meaningful support for:

• Chronic pain management

• Fibromyalgia symptom reduction

• Sleep support

• Functional mobility

• Medication reduction

• Nervous system regulation

• Quality of life enhancement

Study Details

Study Type: Open-Label Repeated-Measures Clinical Study
Participants: 19
Published: Clinical medical journal study
Frequency Used: 40Hz